Drug Search Results
More Filters [+]

CV-7202

Alternative Names: CV-7202, CV7202, CV 7202
Latest Update: 2021-12-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: CureVac
Company Location: BADEN-WURTTEMBERG 2M 72076
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CV-7202

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Rabies

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CV-7202-104

P1

Completed

Rabies

2021-11-23

22%

Recent News Events